Clinical value of serum tumour markers CEA, CA 50 and CA 242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis; results from a prospective study (Q54099073)
Jump to navigation
Jump to search
scientific article published on September 1, 1992
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical value of serum tumour markers CEA, CA 50 and CA 242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis; results from a prospective study |
scientific article published on September 1, 1992 |
Statements
Clinical value of serum tumour markers CEA, CA 50 and CA 242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis; results from a prospective study (English)
P. A. Pasanen
M. Eskelinen
K. Partanen
P. Pikkarainen
I. Penttilä
1 September 1992
12
5
1687-1693